Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-09-11

FDA Approved: VIBATIV — Original Application (Cumberland Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Vibativ (telavancin hydrochloride) through an original NDA for the treatment of hospital-acquired bacterial pneumonia and complicated skin and skin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vibativ (telavancin)

Snippet

ORIG AP for VIBATIV (TELAVANCIN HYDROCHLORIDE)